| |
| |
|
| Insider
Information: |
Martell Ron |
| Relationship: |
President, CEO & Direc... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
904,261 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,391,795 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
904,261 |
|
|
| Total
Value |
$5,391,795 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Poniard Pharmaceuticals |
PARD |
Chief Executive Office... |
2011-10-06 |
548,073 |
2010-03-25 |
0 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
President and CEO |
2013-01-01 |
25,000 |
2013-01-01 |
0 |
Premium* |
|
|
Amplitude Healthcare Acquisition... |
AMHCU |
President, CEO & Direc... |
2023-10-12 |
331,188 |
2022-10-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMHCU |
Amplitude Healthcare Acqu... |
President, CEO & Director |
• • – |
2023-10-12 |
4 |
D |
$0.85 |
$74,401 |
D/D |
(87,531) |
331,188 |
0 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
President, CEO and Director |
• • – |
2023-04-12 |
4 |
D |
$1.46 |
$127,795 |
D/D |
(87,531) |
418,719 |
0 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
President, CEO and Director |
• • – |
2022-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
506,250 |
506,250 |
0 |
- |
|
| NGSX |
Neurogesx Inc |
President and CEO |
• – – |
2013-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Chief Executive Officer |
• • – |
2011-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
548,073 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Chief Executive Officer |
• • – |
2011-04-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
162,500 |
523,073 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Chief Executive Officer |
• • – |
2011-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
360,573 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Chief Executive Officer |
• • – |
2010-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
292,208 |
304,323 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Chief Executive Officer |
• • – |
2010-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
329,323 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Chief Executive Officer |
• • – |
2010-03-25 |
4 |
B |
$1.24 |
$15,047 |
D/D |
12,115 |
12,115 |
2.81 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
